Clinical Core
- Institution
- Stanford University, CA
- Principal investigator
- R. Sharon Chinthrajah
- Funding
- $256K
- Duration
- 2003–2029
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY The objective of our Cooperative Center for Human Immunology (CCHI) is to use the analysis of vaccine induced immunity and natural infections to Influenza and Sars COV-2 as a model for defining adaptive and innate immune mechanisms and antiviral protection in adults. The Clinical Core will be responsible for coordinating protocol design and implementation to maximize opportunities for parallel evaluations across the research projects and scientific cores, obtaining human subjects approvals, and creating and managing the centralized database to record clinical data. The Clinical Core will coordinate distribution of relevant specimens to the HIMC Core and provide matched de-identified clinical data for analysis. As the work proceeds, the Clinical Core database will facilitate comparative analyses of results obtained from the individual research projects. One of the goals of the Clinical Core is to make the necessary IRB submissions for clinical studies, recruit and enroll adults into the protocols, assure that participant rights are respected throughout the duration of their trial participation and provide follow-up to assure collection of complete sets of data from all subjects. Participant reimbursement payments will be provided by the core. We will provide centralized clinical data management for research projects and other cores using an electronic database with electronic data entry and implement a quality management plan to assure data integrity. These data will then be made available to the research projects and scientific cores for final data analysis. Biospecimens (blood) and clinical data will be collected by the Clinical Core staff according to the specifications of each clinical study protocol and delivered either to the CTRU laboratory or directly to research project staff.
LOADING MOONBASE SCORE
Questions for Stanford University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Stanford UniversityNot yet scored
A randomized, double blind, placebo controlled, phase 2 study testing the use of combination multi-allergen food desensitization with dupilumab or omalizumab in multi-food allergic individuals
R. Sharon Chinthrajah · $97K · 2013–2026
- NIH · Stanford University60
Dissecting neocortical field potential dynamics using optical voltage imaging in genetically targeted cell-types
Mark J Schnitzer · $604K · 2021–2027
- NIH · Stanford University48
Clinical Translation of Ultrasonic Ketamine Uncaging for Non-Opioid Therapy of Chronic Pain
Raag D Airan · $1.3M · 2019–2026